Objective Mobility Assessment Using Wearable Technology for Clinical Application in Parkinson's Disease: From Validation to Fall Prediction
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Step Time
研究概览
简要总结
The main objective of this observational trial is to explore the validity and reliability of DANU smart socks when used for mobility assessments in people with Parkinson's. Using a series of laboratory gold standard equipment, this project aims to compare the metrics observed by DANU to the reference standards. No intervention is included. Specifically, this study will explore metrics relating to walking (gait) and balance of a Parkinson's cohort through a series of motor tasks. Moreover, this study seeks to investigate the clinical validity of DANU outcome metrics exploring relationships with clinical scales, fall history and prospective falls.
详细描述
Background:
Mobility impairments are common in Parkinson's disease (PD) and increase the risk of falling. Data derived from wearable inertial measurement units can provide useful information regarding gait in different situations and environments, which may help to identify those at risk of falling. However, rigorous testing is required to evaluate whether new devices are fit for purpose. DANU Smart Socks are a multi-modal system for movement analysis, containing 15 silicone based capacitive pressure sensors and an IMU pod, with tri-axal accelerometers, gyroscope and magnetometers, currently at use within a sporting context. Potential has been highlighted for clinical use in people with Parkinson's (PwP). This study aims to evaluate the validity, reliability and usability of the DANU Sport System in PwP for balance and gait assessment. The V3+ framework for determining fit-for-purpose biometric monitoring devices will be employed, evaluating verification, usability, analytical and clinical validation.
Methods:
Institutional ethics have been obtained (Project ID: 8543). Utilising a a repeated measures observational design, participants will be asked to attend two visits to Northumbria University, Newcastle Upon Tyne.
Visit 1: Participants will complete a series of clinical and cognitive measures including the Movement Disorders Society's-Unified Parkinson's Disease Rating Scale, Montreal Cognitive Assessment, Freezing of Gait Questionnaire and Falls Efficacy Scale. Following this, concurrent data collection will occur throughout a battery of motor tasks to observe gait/balance metrics. Laboratory references employed include Axivity AX6, Vicon 3D Motion Capture, APDM Mobility Lab, GAITRite and AMTI Force Plates. Mobility assessments include a 2-Minute Walk Test, 3 walkway trials, a Timed Up and Go and a series of 2-Minute Balance tasks.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 50 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical diagnosis of Parkinson's by a movement disorder specialist according to UK brain bank criteria.
- •Hoehn & Yahr stages I-III
- •Able to attend Northumbria University, Newcastle Upon Tyne for study visits
- •Able to walk and stand unassisted for a minimum of 2-minutes
排除标准
- •History of neurological disorders other than PD (e.g., Huntington's disease, stroke, traumatic brain injury, multiple sclerosis, Alzheimer's disease etc.)
- •Montreal Cognitive Assessment (MoCA) score < 21
- •Injury to the lower extremities within the past 6-weeks.
研究组 & 干预措施
Parkinson's Disease (PD)
People with a clinical diagnosis of Parkinson's Disease will be recruited to participate within the study. All participants must fit within the described eligibility criteria.
Within the verification and analytical validation phase 30 people with Parkinson's will be recruited and within clinical validation 60 individuals will be recruited.
结局指标
主要结局
Step Time
时间窗: Outcomes will be obtained on Visit 1 (Day 1) and Visit 2 (Day 8).
(s, mean ± standard deviation)
Stride Time
时间窗: Outcomes will be obtained on Visit 1 (Day 1) and Visit 2 (Day 8).
(s, mean ± standard deviation)
Cadence
时间窗: Outcomes will be obtained on Visit 1 (Day 1) and Visit 2 (Day 8).
(steps per minute, mean ± standard deviation)
Stride Length
时间窗: Outcomes will be obtained on Visit 1 (Day 1) and Visit 2 (Day 8).
(m, mean ± standard deviation)
Ground Contact Time
时间窗: Outcomes will be obtained on Visit 1 (Day 1) and Visit 2 (Day 8).
(s, mean ± standard deviation)
Swing Time
时间窗: Outcomes will be obtained on Visit 1 (Day 1) and Visit 2 (Day 8).
(s, mean ± standard deviation)
Stride Velocity
时间窗: Outcomes will be obtained on Visit 1 (Day 1) and Visit 2 (Day 8).
(m/s, mean ± standard deviation)
Gait Velocity
时间窗: Outcomes will be obtained on Visit 1 (Day 1) and Visit 2 (Day 8).
(m/s, mean ± standard deviation)
Area of Ellipse
时间窗: Outcomes will be obtained on Visit 1 (Day 1) and Visit 2 (Day 8).
(mm², mean ± standard deviation)
Length of Ellipse
时间窗: Outcomes will be obtained on Visit 1 (Day 1) and Visit 2 (Day 8).
(mm, mean ± standard deviation)
Width of Ellipse
时间窗: Outcomes will be obtained on Visit 1 (Day 1) and Visit 2 (Day 8).
(mm, mean ± standard deviation)
Total Displacement
时间窗: Outcomes will be obtained on Visit 1 (Day 1) and Visit 2 (Day 8).
(mm, mean ± standard deviation)
Medio-Lateral Range
时间窗: Outcomes will be obtained on Visit 1 (Day 1) and Visit 2 (Day 8).
(mm, mean ± standard deviation)
Anterior-Posterior Range
时间窗: Outcomes will be obtained on Visit 1 (Day 1) and Visit 2 (Day 8).
(mm, mean ± standard deviation)
次要结局
未报告次要终点
研究者
GabriellaGatti
Postgraduate Researcher
Northumbria University
